There are multiple treatment options for presbyopia, from simple solutions such as reading glasses or contact lenses to more complex procedures such as refractive eye surgery. Presbyopia is the ...

It’s possible to have presbyopia and astigmatism at the same time. Treatments such as prescription contacts or glasses and eye surgery can help correct both conditions. Astigmatism and presbyopia are ...

Presbyopia is an eye condition that causes a reduced ability to see things up close. It occurs when the eye’s lens stops focusing light correctly on the retina and usually develops later in life. The ...

Credit: Lenz Therapeutics. Aceclidine is a cholinergic muscarinic agonist that causes contraction of the iris sphincter muscle, thereby creating a pinhole effect that extends focus depth to improve ...

Please provide your email address to receive an email when new articles are posted on . Outside of eye care, the term “presbyopia” is not commonly used or well understood — and it’s one that can be ...

In its latest webinar, Optician explored the psychological effects of the ageing eye on patients and heard from Bausch + Lomb ...

Please provide your email address to receive an email when new articles are posted on . Presbyopia is the second most common refractive error we deal with as ...

The first FDA-approved eye drops to treat age-related blurry near vision (presbyopia) has gone on sale in the US, offering a potential alternative to reading glasses for the estimated 128 million ...

Findings showed Brimochol PF significantly improved near vision compared with vehicle solution at all timepoints up to 8 hours (P .008). Topline data were announced from a phase 3 trial evaluating ...

Viatris Inc. (NASDAQ:VTRS) is one of the most undervalued stocks under $30 to buy. On February 25, Viatris announced that the FDA accepted its sNDA for MR-141, which is a phentolamine ophthalmic ...

PITTSBURGH, Feb. 25, 2026 /PRNewswire/ -- Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the ...